NTRB (Nutriband) DeferredTaxAndRevenue: $0.03 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NTRB Nutriband Inc NTRB
59 GF Score
Price $3.02
GF Value $3.23
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nutriband DeferredTaxAndRevenue?

Nutriband NTRB 59 DeferredTaxAndRevenue is $0.03 Mil as of Apr. 2026. GuruFocus rates NTRB with a GF Score™ of 59/100 and a GF Value™ of $3.23 (Fairly Valued). The stock has 4 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Nutriband's current deferred tax and revenue for the quarter that ended in Apr. 2026 was $0.03 Mil.

Nutriband DeferredTaxAndRevenue Related Terms

Nutriband DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Nutriband's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutriband DeferredTaxAndRevenue Chart

Nutriband Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.16 0.16 0.16 0.12

Nutriband Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.02 0.01 0.12 0.03
NTRB
59GF Score
Nutriband Inc NTRB
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.03 Mil mean?
Nutriband (NTRB) has a DeferredTaxAndRevenue of $0.03 Mil as of Apr. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Nutriband.
Is Nutriband's DeferredTaxAndRevenue too high?
Nutriband's current DeferredTaxAndRevenue is $0.03 Mil. Overall, Nutriband has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nutriband's DeferredTaxAndRevenue compare to INMB and GRCE?
Nutriband's DeferredTaxAndRevenue of $0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Nutriband. Nutriband's current DeferredTaxAndRevenue is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutriband stock overvalued right now?
Based on GuruFocus' analysis, Nutriband (NTRB) is currently considered Fairly Valued. The stock's GF Value™ is $3.23, compared to a current price of $3.02 — trading 6.5% below its estimated fair value. The current DeferredTaxAndRevenue is $0.03 Mil. Nutriband's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Nutriband (NTRB), the current DeferredTaxAndRevenue is $0.03 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nutriband (NTRB) Overvalued in 2026?

Based on GuruFocus' analysis, Nutriband stock appears to be undervalued. The current stock price of $3.02 is trading 6.5% below its estimated GF Value™ of $3.23. GuruFocus considers Nutriband to be Fairly Valued.

Key valuation signals for NTRB:

  • DeferredTaxAndRevenue: $0.03 Mil
  • GF Value™: $3.23 vs. price of $3.02 (6.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nutriband Business Description

Address 121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
59GF Score

Get the complete analysis for NTRB

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.02
Price
$3.23
GF Value